Table 1

Patient characteristics

Patient characteristics

%


Number

Total included

42

100

Assessable for response

39

93


Sex

Male

31

74

Female

11

26


Age (years)

Median

64

Range

25–75


Performance status

0

18

43

1

17

41

2

7

17


MSKCC risk classification

Favorable

3

7

Intermediate

23

55

Poor

16

38


Previous treatments

Nephrectomy

35

83

Interferon-α

13

31

Interferon-α + chemotherapy

6

14

Radiotherapy

14*

33


* Radiotherapy was directed against the primary tumor bed (as "adjuvant") in three patients; the rest (11 patients) received radiotherapy to the metastatic site (bone)

Kontovinis et al. BMC Cancer 2009 9:82   doi:10.1186/1471-2407-9-82

Open Data